Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease

Ann Hematol. 2002 Jan;81(1):57-8. doi: 10.1007/s00277-001-0406-7. Epub 2001 Dec 13.

Authors

S Kömürcü, A Ozet, M K Altundag, F Arpaci, B Oztürk, B Celasun, Y Tezcan

PMID: 11807639
DOI: 10.1007/s00277-001-0406-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bleomycin / adverse effects
Bleomycin / therapeutic use
Cholestasis, Intrahepatic / etiology*
Cholestasis, Intrahepatic / physiopathology
Combined Modality Therapy / adverse effects
Dacarbazine / adverse effects
Dacarbazine / therapeutic use
Doxorubicin / adverse effects
Doxorubicin / therapeutic use
Hematopoietic Stem Cell Transplantation / adverse effects*
Hodgkin Disease / therapy*
Humans
Male
Syndrome
Transplantation, Autologous
Vinblastine / adverse effects
Vinblastine / therapeutic use

Substances

Bleomycin
Vinblastine
Dacarbazine
Doxorubicin